S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.05%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.05%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.05%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
S&P 500   5,254.35 (+0.11%)
DOW   39,807.37 (+0.12%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.05%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)

Humana (HUM) Stock Price, News & Analysis

$346.72
-2.78 (-0.80%)
(As of 04:10 PM ET)
Today's Range
$345.89
$350.94
50-Day Range
$337.92
$447.76
52-Week Range
$334.54
$541.21
Volume
1.55 million shs
Average Volume
2.00 million shs
Market Capitalization
$41.83 billion
P/E Ratio
17.49
Dividend Yield
1.02%
Price Target
$494.00

Humana MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
42.6% Upside
$494.00 Price Target
Short Interest
Healthy
2.14% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.75
Upright™ Environmental Score
News Sentiment
0.57mentions of Humana in the last 14 days
Based on 9 Articles This Week
Insider Trading
Acquiring Shares
$200,064 Bought Last Quarter
Proj. Earnings Growth
48.38%
From $16.04 to $23.80 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

5.00 out of 5 stars

Medical Sector

1st out of 938 stocks

Hospital & Medical Service Plans Industry

1st out of 11 stocks

HUM stock logo

About Humana Stock (NYSE:HUM)

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

HUM Stock Price History

HUM Stock News Headlines

Is UnitedHealth Group Stock a Strong Buy or a Falling Knife? (HUM)
After two weeks of bad news that has erased almost a year of gains, interested buyers may want to wait for confirmation of support before buying UNH stock
Is Now Time to Buy Humana Stock?
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Humana Inc's Dividend Analysis
Raymond James Initiates Coverage on Humana (NYSE:HUM)
Decoding 15 Analyst Evaluations For Humana
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
What Caused Humana's Shocking Earnings Miss?
Humana (NYSE:HUM) Issues FY 2024 Earnings Guidance
HUM Mar 2024 332.500 call
Humana Inc.: Downgrading to HOLD from BUY
Humana prices more than $2B debt offering
Humana prices $2.25B debt offering
See More Headlines
Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/26 Dividend
12/28/2023
Last Earnings
1/25/2024
Dividend Payable
1/26/2024
Ex-Dividend for 4/26 Dividend
3/27/2024
Today
3/28/2024
Next Earnings (Confirmed)
4/24/2024
Dividend Payable
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
CUSIP
44485910
Employees
67,600
Year Founded
1961

Price Target and Rating

Average Stock Price Target
$494.00
High Stock Price Target
$630.00
Low Stock Price Target
$356.00
Potential Upside/Downside
+41.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
18 Analysts

Profitability

Net Income
$2.49 billion
Pretax Margin
3.18%

Debt

Sales & Book Value

Annual Sales
$106.37 billion
Cash Flow
$34.37 per share
Book Value
$132.55 per share

Miscellaneous

Free Float
120,267,000
Market Cap
$42.17 billion
Optionable
Optionable
Beta
0.45

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Should I Buy Humana Stock? HUM Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Humana was last updated on Monday, March 25, 2024 at 12:04 PM.

Pros

Here are some ways that investors could benefit from investing in Humana Inc.:

  • Humana's quarterly revenue increased by 17.9% year-over-year, indicating strong growth potential.
  • The company has a solid return on equity of 19.44%, showcasing efficient use of shareholder funds.
  • Humana announced a quarterly dividend with a yield of 1.01%, providing investors with a steady income stream.
  • Insider buying activity, such as Director Jorge S. Mesquita purchasing shares, can signal confidence in the company's future performance.
  • Analysts have given Humana a consensus rating of "Moderate Buy" with an average target price of $494.00, suggesting positive sentiment towards the stock.

Cons

Investors should be bearish about investing in Humana Inc. for these reasons:

  • Some analysts have downgraded Humana's rating or lowered their target price, indicating potential concerns about future performance.
  • Humana's payout ratio is currently at 17.86%, which may limit the company's ability to reinvest in growth opportunities.
  • Recent price target reductions by analysts, like Mizuho lowering the target price from $550.00 to $400.00, could suggest a less optimistic outlook on the stock.
  • Market volatility and regulatory changes in the healthcare sector could impact Humana's financial performance and stock price.
  • Investors should closely monitor any changes in government healthcare policies that could affect Humana's business operations and profitability.

HUM Stock Analysis - Frequently Asked Questions

Should I buy or sell Humana stock right now?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last twelve months. There are currently 9 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HUM shares.
View HUM analyst ratings
or view top-rated stocks.

What is Humana's stock price target for 2024?

18 brokers have issued 1 year price targets for Humana's stock. Their HUM share price targets range from $356.00 to $630.00. On average, they predict the company's stock price to reach $494.00 in the next year. This suggests a possible upside of 42.6% from the stock's current price.
View analysts price targets for HUM
or view top-rated stocks among Wall Street analysts.

How have HUM shares performed in 2024?

Humana's stock was trading at $457.81 at the start of the year. Since then, HUM stock has decreased by 24.3% and is now trading at $346.54.
View the best growth stocks for 2024 here
.

Are investors shorting Humana?

Humana saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 2,570,000 shares, an increase of 14.7% from the February 29th total of 2,240,000 shares. Based on an average daily trading volume, of 1,940,000 shares, the days-to-cover ratio is presently 1.3 days. Approximately 2.1% of the shares of the company are sold short.
View Humana's Short Interest
.

When is Humana's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our HUM earnings forecast
.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) posted its quarterly earnings data on Thursday, January, 25th. The insurance provider reported ($0.11) EPS for the quarter, missing the consensus estimate of $0.76 by $0.87. The insurance provider had revenue of $26.46 billion for the quarter, compared to the consensus estimate of $25.47 billion. Humana had a trailing twelve-month return on equity of 19.44% and a net margin of 2.34%. The business's revenue for the quarter was up 17.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.62 earnings per share.
Read the conference call transcript
.

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Thursday, February 15th. Investors of record on Friday, March 29th will be paid a dividend of $0.885 per share on Friday, April 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date is Wednesday, March 27th.
Read our dividend analysis for HUM
.

Is Humana a good dividend stock?

Humana (NYSE:HUM) pays an annual dividend of $3.54 per share and currently has a dividend yield of 1.02%. The company has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 17.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HUM will have a dividend payout ratio of 14.87% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HUM.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY 2024 earnings guidance on Saturday, March, 16th. The company provided earnings per share guidance of 16.000-16.000 for the period, compared to the consensus earnings per share estimate of 16.380. The company issued revenue guidance of -.

What is Bruce D. Broussard's approval rating as Humana's CEO?

1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among the company's employees.

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), Salesforce (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

Who are Humana's major shareholders?

Humana's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.26%), Wellington Management Group LLP (4.45%), Price T Rowe Associates Inc. MD (3.17%), Capital World Investors (1.89%), Capital Research Global Investors (1.63%) and Norges Bank (1.20%). Insiders that own company stock include Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, Jorge S Mesquita, Joseph C Ventura, Samir Deshpande, Susan M Diamond, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming.
View institutional ownership trends
.

How do I buy shares of Humana?

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Humana have any subsidiaries?
The following companies are subsidiares of Humana: 154th Street Medical Plaza, 516-526 West Main Street Condominium Council of Co-Owners, 54th Street Medical Plaza, American Eldercare, American Eldercare of North Florida, Anvita Health, Arcadian Health Plan, Arcadian Management Services, Atlantis Physician Group, CAC Medical Center Holdings, CAC-Florida Medical Centers, CDO 1, CDO 2, CHA HMO, CHA Service Company, Care Partners Home Care, CareNetwork, CarePlus Health, CarePlus Health Plans, Cariten Health Plan Inc., Certify Data Systems, CompBenefits, CompBenefits Company, CompBenefits Corporation, CompBenefits Dental, CompBenefits Direct, CompBenefits Insurance Company, Complex Clinical Management, Concentra Managed Care, Continucare Corporation, Continucare MDHC, Continucare MSO, Continucare Medical Management, Dental Care Plus Management, DentiCare, Emphesys, Emphesys Insurance Company, Enclara Healthcare, FPG, FPG Acquisition Corp., FPG Acquisition Holdings Corp., FPG Senior Services, Family Physicians of Winter Park, Go365, HUM Provider Holdings, HUM-e-FL, Harris Rothenberg International, Health Value Management, Humana Active Outlook, Humana At Home (Dallas), Humana At Home (Houston), Humana At Home (San Antonio), Humana At Home (TLC), Humana At Home 1, Humana Behavioral Health, Humana Benefit Plan of Illinois, Humana Dental Company, Humana Digital Health and Analytics Platform Services, Humana EAP and Work-Life Services of California, Humana Employers Health Plan of Georgia, Humana Government Business, Humana Health Benefit Plan of Louisiana, Humana Health Company of New York, Humana Health Insurance Company of Florida, Humana Health Plan, Humana Health Plan of California, Humana Health Plan of Ohio, Humana Health Plan of Texas, Humana Health Plans of Puerto Rico, Humana Healthcare Research, Humana Inc., Humana Innovation Enterprises, Humana Insurance Company, Humana Insurance Company of Kentucky, Humana Insurance Company of New York, Humana Insurance of Puerto Rico, Humana Management Services of Puerto Rico, Humana MarketPOINT, Humana MarketPOINT of Puerto Rico, Humana Medical Plan, Humana Medical Plan of Michigan, Humana Medical Plan of Pennsylvania, Humana Medical Plan of Utah, Humana Pharmacy, Humana Pharmacy Solutions, Humana Regional Health Plan, Humana Veterans Healthcare Services, Humana WellWorks LLC, Humana Wisconsin Health Organization Insurance Corporation, Humana at Home, HumanaDental, HumanaDental Insurance Company, Humco, Hummingbird Coaching Systems LLC, Independent Care Health Plan, KMG America, Kindred Healthcare, MCCI Group Holdings, MCCI Holdings, MCCI Medical Group, MCCI Specialty, MCCI/Lifetime of Aventura, MD Care, METCARE of Florida, Managed Care Indemnity, Medical Care Consortium Incorporated of Texas, MetCare, Metropolitan Health Networks, Naples Health Care Specialists, North Region Providers, Nursing Solutions, OSF HealthCare, PHP Companies, Partners in Integrated Care, Preferred Health Partnership, Preservation on Main, Primary Care Holdings, Primary Care Holdings II, Primary Care Specialists of the Palm Beaches, RMA Medical Centers of Florida, RMA Medical Group of Florida, ROHC, SeniorBridge, SeniorBridge Family Companies (CT), SeniorBridge Family Companies (FL), SeniorBridge Family Companies (IN), SeniorBridge Family Companies (MO), SeniorBridge Family Companies (NY), SeniorBridge-Florida, Texas Dental Plans, The Dental Concern, Transcend Population Health Management, and Transcend Population Health Management II.
Read More
This page (NYSE:HUM) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners